Using a rapid communication approach to improve a POC Chlamydia test

Elizabeth A. Hesse, Sabre A. Patton, Jill S. Huppert, Charlotte A Gaydos

Research output: Contribution to journalArticle

Abstract

Chlamydia trachomatis is a common sexually transmitted infection in young women. Available point-of-care (POC) diagnostic tests perform poorly, but development of new devices can be costly and time consuming. We explored the feasibility (user friendliness) and test characteristics (sensitivity and specificity) of a new prototype device to detect Chlamydia in adolescent women by using small numbers of subjects and rapid communication with the manufacturer. We compared cervical POC test results to the gold standard (cervical nucleic acid amplification testing). We also assessed the accuracy of the POC test on self-collected vaginal swabs by comparing results to cervical nucleic acid amplification test and to the cervical POC test. We frequently reviewed user experience and test results with the manufacturer. The results showed the feasibility and accuracy of the device. Feasibility - initial device malfunctions were identified and corrected. This device would be easy to use in a nonclinical setting, as it is self-contained and the color change for some specimens was dramatic and immediate. Accuracy - initial prototypes demonstrated low sensitivities (38%) for vaginal and cervical swabs. After feedback, the company developed new prototypes with improved sensitivity (80%). However, the increased sensitivity was accompanied by a high percentage of indeterminate results and false positives that lowered specificity.

Original languageEnglish (US)
Pages (from-to)837-840
Number of pages4
JournalIEEE Transactions on Biomedical Engineering
Volume58
Issue number3 PART 2
DOIs
StatePublished - Mar 2011

Fingerprint

Nucleic acids
Amplification
Communication
Color
Feedback
Testing
Industry

Keywords

  • Adolescent
  • Chlamydia trachomatis (CT)
  • diagnosis
  • point-of-care (POC)
  • sexually transmitted infection (STI)

ASJC Scopus subject areas

  • Biomedical Engineering

Cite this

Using a rapid communication approach to improve a POC Chlamydia test. / Hesse, Elizabeth A.; Patton, Sabre A.; Huppert, Jill S.; Gaydos, Charlotte A.

In: IEEE Transactions on Biomedical Engineering, Vol. 58, No. 3 PART 2, 03.2011, p. 837-840.

Research output: Contribution to journalArticle

Hesse, Elizabeth A. ; Patton, Sabre A. ; Huppert, Jill S. ; Gaydos, Charlotte A. / Using a rapid communication approach to improve a POC Chlamydia test. In: IEEE Transactions on Biomedical Engineering. 2011 ; Vol. 58, No. 3 PART 2. pp. 837-840.
@article{b0bb483032714279af7f67c8389866b9,
title = "Using a rapid communication approach to improve a POC Chlamydia test",
abstract = "Chlamydia trachomatis is a common sexually transmitted infection in young women. Available point-of-care (POC) diagnostic tests perform poorly, but development of new devices can be costly and time consuming. We explored the feasibility (user friendliness) and test characteristics (sensitivity and specificity) of a new prototype device to detect Chlamydia in adolescent women by using small numbers of subjects and rapid communication with the manufacturer. We compared cervical POC test results to the gold standard (cervical nucleic acid amplification testing). We also assessed the accuracy of the POC test on self-collected vaginal swabs by comparing results to cervical nucleic acid amplification test and to the cervical POC test. We frequently reviewed user experience and test results with the manufacturer. The results showed the feasibility and accuracy of the device. Feasibility - initial device malfunctions were identified and corrected. This device would be easy to use in a nonclinical setting, as it is self-contained and the color change for some specimens was dramatic and immediate. Accuracy - initial prototypes demonstrated low sensitivities (38{\%}) for vaginal and cervical swabs. After feedback, the company developed new prototypes with improved sensitivity (80{\%}). However, the increased sensitivity was accompanied by a high percentage of indeterminate results and false positives that lowered specificity.",
keywords = "Adolescent, Chlamydia trachomatis (CT), diagnosis, point-of-care (POC), sexually transmitted infection (STI)",
author = "Hesse, {Elizabeth A.} and Patton, {Sabre A.} and Huppert, {Jill S.} and Gaydos, {Charlotte A}",
year = "2011",
month = "3",
doi = "10.1109/TBME.2010.2085003",
language = "English (US)",
volume = "58",
pages = "837--840",
journal = "IEEE Transactions on Biomedical Engineering",
issn = "0018-9294",
publisher = "IEEE Computer Society",
number = "3 PART 2",

}

TY - JOUR

T1 - Using a rapid communication approach to improve a POC Chlamydia test

AU - Hesse, Elizabeth A.

AU - Patton, Sabre A.

AU - Huppert, Jill S.

AU - Gaydos, Charlotte A

PY - 2011/3

Y1 - 2011/3

N2 - Chlamydia trachomatis is a common sexually transmitted infection in young women. Available point-of-care (POC) diagnostic tests perform poorly, but development of new devices can be costly and time consuming. We explored the feasibility (user friendliness) and test characteristics (sensitivity and specificity) of a new prototype device to detect Chlamydia in adolescent women by using small numbers of subjects and rapid communication with the manufacturer. We compared cervical POC test results to the gold standard (cervical nucleic acid amplification testing). We also assessed the accuracy of the POC test on self-collected vaginal swabs by comparing results to cervical nucleic acid amplification test and to the cervical POC test. We frequently reviewed user experience and test results with the manufacturer. The results showed the feasibility and accuracy of the device. Feasibility - initial device malfunctions were identified and corrected. This device would be easy to use in a nonclinical setting, as it is self-contained and the color change for some specimens was dramatic and immediate. Accuracy - initial prototypes demonstrated low sensitivities (38%) for vaginal and cervical swabs. After feedback, the company developed new prototypes with improved sensitivity (80%). However, the increased sensitivity was accompanied by a high percentage of indeterminate results and false positives that lowered specificity.

AB - Chlamydia trachomatis is a common sexually transmitted infection in young women. Available point-of-care (POC) diagnostic tests perform poorly, but development of new devices can be costly and time consuming. We explored the feasibility (user friendliness) and test characteristics (sensitivity and specificity) of a new prototype device to detect Chlamydia in adolescent women by using small numbers of subjects and rapid communication with the manufacturer. We compared cervical POC test results to the gold standard (cervical nucleic acid amplification testing). We also assessed the accuracy of the POC test on self-collected vaginal swabs by comparing results to cervical nucleic acid amplification test and to the cervical POC test. We frequently reviewed user experience and test results with the manufacturer. The results showed the feasibility and accuracy of the device. Feasibility - initial device malfunctions were identified and corrected. This device would be easy to use in a nonclinical setting, as it is self-contained and the color change for some specimens was dramatic and immediate. Accuracy - initial prototypes demonstrated low sensitivities (38%) for vaginal and cervical swabs. After feedback, the company developed new prototypes with improved sensitivity (80%). However, the increased sensitivity was accompanied by a high percentage of indeterminate results and false positives that lowered specificity.

KW - Adolescent

KW - Chlamydia trachomatis (CT)

KW - diagnosis

KW - point-of-care (POC)

KW - sexually transmitted infection (STI)

UR - http://www.scopus.com/inward/record.url?scp=79952029649&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79952029649&partnerID=8YFLogxK

U2 - 10.1109/TBME.2010.2085003

DO - 10.1109/TBME.2010.2085003

M3 - Article

C2 - 20934941

AN - SCOPUS:79952029649

VL - 58

SP - 837

EP - 840

JO - IEEE Transactions on Biomedical Engineering

JF - IEEE Transactions on Biomedical Engineering

SN - 0018-9294

IS - 3 PART 2

ER -